KAB Biotech Holding ApS: Financial statements 2019
CVR: 37692646
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
KAB Biotech Holding ApS (CVR 37692646) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -17,000 and a net result of DKK 7,466,344 compared with DKK 9,892,311 the year before. Equity in the 2019 report amounted to DKK 24,619,103. The solvency ratio was 94%.
- Gross Profit
- DKK -17,000
- Profit/Loss
- DKK 7,466,344
- Equity
- DKK 24,619,103
- Total Assets
- DKK 26,196,649
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -17K | 7.5M | 24.6M | 0 |
| 2018 | - | -17K | 9.9M | 17.2M | - |
| 2017 | - | -16K | 457K | 7.3M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
KAB Biotech Holding ApS has published its annual report for 2018. Gross profit came to DKK -17,000, and the net result was DKK 9,892,311.
About KAB Biotech Holding ApS
KAB Biotech Holding ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved on 17 August 2020. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2019 annual report, the company had an average of 0 employees. In 2019, the company reported a gross profit of DKK -17,000 and a net result of DKK 7,466,344 compared with DKK 9,892,311 the year before. Equity in the 2019 report amounted to DKK 24,619,103.